81927-201 : Imkeldi 80 mg/ml Oral Solution
| NDC: | 81927-201 |
| Labeler: | Shorla Oncology Inc., |
| Product Type: | Human Prescription Drug |
| Drug Name: | Imkeldi |
| Dosage Form: | Oral Solution |
| Application #: | NDA219097 |
| Rev. Date: |
NDC Package Codes:
- 81927-201-01: 140 ML IN 1 BOTTLE (81927‑201‑01)
Active Ingredients:
- Imatinib Mesylate
Dosage Strength:
- 80 mg/mL
Pharmaceutical Classes:
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Kinase Inhibitor [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 81927-111Next: 81927-204 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.